首页> 外国专利> HUMANIZED ANTIBODY FOR TREATING OR PREVENTING DEMENTIA AND PRODUCTION METHOD THEREFOR AND THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA USING SAME

HUMANIZED ANTIBODY FOR TREATING OR PREVENTING DEMENTIA AND PRODUCTION METHOD THEREFOR AND THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA USING SAME

机译:治疗或预防痴呆的人源化抗体及其生产方法以及使用相同的痴呆的治疗剂或预防剂

摘要

PROBLEM TO BE SOLVED: To provide a humanized anti-phosphorylated tau antibody applicable as a therapeutic or prophylactic agent for dementia such as tauopathy in humans with reduced antigenicity to humans without substantially impairing the binding properties of mouse monoclonal anti-phosphorylated tau antibody to phosphorylated tau.SOLUTION: A humanized antibody or a fragment thereof that undergoes an antigen-antibody reaction with tau protein or tau peptide phosphorylated at least by an amino acid residue corresponding to Ser 413 among specific amino acid sequences, or a derivative thereof.SELECTED DRAWING: Figure 3
机译:有待解决的问题:提供一种人源化的抗磷酸化tau抗体,该抗体可作为人中的tau病等痴呆症的治疗剂或预防剂,对人的抗原性降低,而又不显着损害小鼠单克隆抗磷酸化tau抗体与磷酸化tau的结合特性解决方案:人源化抗体或其片段与tau蛋白或tau肽进行抗原-抗体反应,该tau蛋白或tau肽至少被特定氨基酸序列中对应于Ser 413的氨基酸残基磷酸化,或其衍生物。 3

著录项

  • 公开/公告号JP2018139530A

    专利类型

  • 公开/公告日2018-09-13

    原文格式PDF

  • 申请/专利权人 TEIJIN PHARMA LTD;

    申请/专利号JP20170035594

  • 申请日2017-02-27

  • 分类号C12N15/09;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08;C07K16/28;A61K39/395;A61P25/28;A61P25/14;A61P25/16;

  • 国家 JP

  • 入库时间 2022-08-21 13:14:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号